Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma

NCT03029780

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Cancer Specialists of North FL Jacksonville, Florida, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Local Institution Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

NCT01664182

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

NCT01354431

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Ucla Los Angeles, California, United States
  • Samuel Oschin Comprehensive Cancer Inst. Los Angeles, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 41 locations
View Trial Details
Completed

A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

NCT04115189

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Instituto Médico Especializado Alexander Fleming Buenos Aires, Argentina
  • Sanatorio del Salvador - Cordoba Córdoba, Argentina
  • Centro Oncológico de Integración Regional in Mendoza Mendoza, Argentina
  • Escola Paulista de Medicina - UNIFESP São Paulo, Brazil
View Trial Details
Completed

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

NCT03633110

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

NCT02646748

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +59 more
Locations
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica, California, United States
  • Georgetown University Medical Center Lombardi CCC Washington D.C., District of Columbia, United States
  • Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 17 locations
View Trial Details
Completed

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

NCT02526017

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +47 more
Locations
  • Scottsdale Healthcare Hospitals DBA Honor Health Scottsdale, Arizona, United States
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Norris Comprehensive Cancer Center, University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States
View all 39 locations
View Trial Details

Related conditions